Laboratorios Farma | ROVI

Stock Price
59.65
Daily Change
-0.10 -0.17%
Monthly
14.71%
Yearly
-26.18%
Q3 Forecast
59.21

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Almirall 10.96 -0.16 -1.44% 27.89% Sep/05
Tectonic Therapeutic 16.80 -0.47 -2.72% -8.50% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Moderna 25.14 0.86 3.54% -65.54% Sep/05
Organon & Co 10.38 0.70 7.23% -49.40% Sep/05
Pharma Mar 88.40 -2.80 -3.07% 116.88% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Laboratorios Farma 59.65 -0.10 -0.17% -26.18% Sep/05
Viatris 10.50 0.17 1.65% -6.87% Sep/05
Xeris Pharmaceuticals 7.85 -0.04 -0.51% 212.75% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05

Indexes Price Day Year Date
ES35 14851 -67.40 -0.45% 32.92% Sep/05

Laboratorios Farma traded at 59.65 this Friday September 5th, decreasing 0.10 or 0.17 percent since the previous trading session. Looking back, over the last four weeks, Laboratorios Farma lost 14.71 percent. Over the last 12 months, its price fell by 26.18 percent. Looking ahead, we forecast Laboratorios Farma to be priced at 59.21 by the end of this quarter and at 57.93 in one year, according to Trading Economics global macro models projections and analysts expectations.

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.